Commit To Buy Pieris Pharmaceuticals At $2.50, Earn 17.7% Annualized Using Options
January 06, 2020 at 12:08 PM EST
Investors eyeing a purchase of Pieris Pharmaceuticals Inc (PIRS) shares, but tentative about paying the going market price of $3.44/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $2.50 strike, which has a bid at the time of this writing of 20 cents..